# US 2012/0251565 A1 · Compositions and methods for preventing or treating burkholderia infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251565 A1
- Document ID: US20120251565A1
- Status: Published application
- Kind: A1
- Application number: 13/424,341
- Filed: 2012-03-19
- Published: 2012-10-04
- Earliest claimed: 2011-03-28
- Assignees: Board of Regents, The University of Texas System
- Inventors: Alfredo G. Torres; D. Mark Estes
- Web page: https://patentgrep.com/patent/US20120251565A1

## CPC

- G01N 33/56911: {Bacteria}
- A61K 39/0208: {Specific bacteria not otherwise provided for}
- A61P 31/04: Antibacterial agents
- A61P 37/04: Immunostimulants
- C07K 14/195: from bacteria
- A61K 2039/543: {intranasal}
- A61K 2039/55561: {CpG containing adjuvants; Oligonucleotide containing adjuvants}
- A61K 2039/55577: {Saponins; Quil A; QS21; ISCOMS}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides a protein or a fragment or a variant of said protein, wherein the protein, fragment, or variant is capable of producing a protective immune response in an animal, wherein the immune response is protective against infection by Burkholderia species. Also provided is a method of preventing or treating infection in an animal caused by Burkholderia species which comprises administering an effective amount of the pharmaceutical composition of the present invention to the animal infected with Burkholderia species.

## Claims

### Claim 1

An immunogenic composition comprising at least one isolated peptide selected from those having an amino acid sequence that is 95% identical to SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a first isolated peptide having an amino acid sequence that is 95% identical to SEQ ID NO:1 and a second isolated peptide having an amino acid sequence that is 95% identical to SEQ ID NO:2 or 95% identical to SEQ ID NO:3.

### Claim 3 (depends on 1)

The composition of claim 1, comprising isolated peptides having an amino acid sequence that is 95% identical to each of SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3.

### Claim 4 (depends on 1)

A method of inducing an immune response in an animal to Burkholderia species comprises administering a composition of claim 1 to the animal.

### Claim 5 (depends on 4)

The method of claim 4, wherein the animal is equine.

### Claim 6 (depends on 4)

The method of claim 4, wherein the animal is human.

### Claim 7 (depends on 4)

The method of claim 4, wherein the Burkholderia is B. mallei, B. pseudomallei, or B. cepacia.

### Claim 8 (depends on 1)

A method of treating a Burkholderia infection by administering an effective amount of the composition of claim 1 to an animal infected with Burkholderia.

### Claim 9 (depends on 8)

The method of claim 8, wherein the Burkholderia is B. mallei, B. pseudomallei, or B. cepacia.

### Claim 10

A method for detecting the presence of B. pseudomallei, B. mallei, or B. cepacia comprising contacting a sample from a subject suspected of having a B. pseudomallei, B. mallei, or B. cepacia infection with a peptide having the amino acid sequence of SEQ ID NO:1, SEQ ID NO:2, and/or SEQ ID NO:3 and detecting Burkholderia binding antibodies in the sample.
